Review: taking Lantus and Victoza together


Summary

Drug interactions are reported among people who take Lantus and Victoza together. This review analyzes the effectiveness and drug interactions between Lantus and Victoza. It is created by eHealthMe based on reports of 1,646 people who take the same drugs from FDA and social media, and is updated regularly.

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Lantus

Lantus has active ingredients of insulin glargine recombinant. It is often used in type 2 diabetes. (latest outcomes from Lantus 94,061 users)

Victoza

Victoza has active ingredients of liraglutide. It is often used in type 2 diabetes. (latest outcomes from Victoza 22,251 users)

On Sep, 17, 2016

1,646 people who take Lantus, Victoza are studied.


Number of reports submitted per year:

Lantus and Victoza drug interactions.

Drug effectiveness over time:

Lantus:
  • < 1 month: 0.0% - (0 of 1 people)
  • 1 - 6 months: 33.0% - (1 of 3 people)
  • 6 - 12 months: 50.0% - (1 of 2 people)
  • 1 - 2 years: 50.0% - (2 of 4 people)
  • 2 - 5 years: 42.0% - (3 of 7 people)
  • 5 - 10 years: 50.0% - (2 of 4 people)
  • 10+ years: 0.0% - (0 of 1 people)
  • not specified: 0.0% - (0 of 0 people)
Victoza:
  • < 1 month: 100.0% - (1 of 1 people)
  • 1 - 6 months: 20.0% - (1 of 5 people)
  • 6 - 12 months: 50.0% - (4 of 8 people)
  • 1 - 2 years: 33.0% - (1 of 3 people)
  • 2 - 5 years: 50.0% - (2 of 4 people)
  • 5 - 10 years: 50.0% - (1 of 2 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 0.0% - (0 of 0 people)

Drug effectiveness by gender:

Lantus:
  • female: 11.0% - (1 of 9 people)
  • male: 61.0% - (8 of 13 people)
Victoza:
  • female: 40.0% - (4 of 10 people)
  • male: 46.0% - (6 of 13 people)

Drug effectiveness by age:

Lantus:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 0.0% - (0 of 0 people)
  • 40-49: 25.0% - (1 of 4 people)
  • 50-59: 41.0% - (5 of 12 people)
  • 60+: 50.0% - (3 of 6 people)
Victoza:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 0.0% - (0 of 0 people)
  • 40-49: 50.0% - (2 of 4 people)
  • 50-59: 53.0% - (7 of 13 people)
  • 60+: 16.0% - (1 of 6 people)

Most common drug interactions over time *:

< 1 month:
  • nausea
  • diarrhoea
  • pancreatitis
  • abdominal pain
  • dehydration
  • vomiting
  • pancreatitis acute
  • abdominal pain upper
  • weight decreased
  • blood glucose increased
1 - 6 months:
  • pancreatitis
  • pancreatic carcinoma
  • intervertebral disc protrusion
  • pancreatitis acute
  • pharyngitis
  • pleurisy
  • rhinitis allergic
  • cholangitis
  • nausea
  • pericarditis
6 - 12 months:
  • pancreatitis
  • pancreatic carcinoma
  • pancreatitis acute
  • glycosylated haemoglobin increased
  • aspartate aminotransferase increased
  • decreased appetite
  • fatigue
  • nausea
  • abdominal pain
  • alanine aminotransferase increased
1 - 2 years:
  • pancreatitis
  • pancreatic carcinoma
  • bladder cancer
  • intervertebral disc protrusion
  • myocardial infarction
  • pancreatic carcinoma metastatic
  • pharyngitis
  • pleurisy
  • rhinitis allergic
  • adenocarcinoma pancreas
2 - 5 years:
  • pancreatitis
  • pancreatic carcinoma
  • blood glucose increased
  • nausea
  • bladder cancer
  • congestive cardiac failure aggravated
  • cystitis chronic
  • diabetic ketoacidosis
  • ear discomfort
  • fatigue - chronic
5 - 10 years:
  • dementia
  • depression
  • diarrhea
  • frequent or urgent urination
  • hyperlipidemia
  • hypertension
  • insomnia
  • nausea
  • burping
  • chills
10+ years:
  • drug administration error
  • gastric cancer
  • weight decreased
  • bladder cancer
  • confusional arousal
  • disorientation
  • dizziness
  • headache
not specified:
  • blood glucose increased
  • nausea
  • weight decreased
  • diarrhoea
  • blood glucose decreased
  • vomiting
  • decreased appetite
  • pancreatitis
  • headache
  • constipation

Most common drug interactions by gender *:

female:
  • blood glucose increased
  • nausea
  • weight decreased
  • diarrhoea
  • pancreatitis
  • vomiting
  • blood glucose decreased
  • headache
  • decreased appetite
  • constipation
male:
  • blood glucose increased
  • nausea
  • pancreatitis
  • blood glucose decreased
  • weight decreased
  • diarrhoea
  • pancreatic carcinoma
  • vomiting
  • decreased appetite
  • drug ineffective

Most common drug interactions by age *:

2-9:
  • disease recurrence
  • retinal vein thrombosis
10-19:
  • diabetic ketoacidosis
  • hypokalaemia
  • pancreatitis acute
  • vulvovaginal rash
  • acute generalised exanthematous pustulosis
20-29:
  • deep vein thrombosis
  • prostatitis
30-39:
  • diabetic ketoacidosis
  • constipation
  • injection site pain
  • oedema
  • weight increased
  • blood creatinine increased
  • blood glucose increased
  • cardiac failure
  • decreased appetite
  • pulmonary oedema
40-49:
  • nausea
  • blood glucose increased
  • diabetic ketoacidosis
  • pancreatitis
  • vomiting
  • weight decreased
  • headache
  • rash
  • renal failure acute
  • constipation
50-59:
  • blood glucose increased
  • nausea
  • pancreatitis
  • weight decreased
  • diarrhoea
  • vomiting
  • pancreatitis acute
  • headache
  • blood glucose decreased
  • fatigue
60+:
  • blood glucose increased
  • nausea
  • diarrhoea
  • blood glucose decreased
  • weight decreased
  • vomiting
  • decreased appetite
  • pancreatic carcinoma
  • pancreatitis
  • dehydration

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Lantus and Victoza?

Can you answer these questions?

More questions for: Lantus, Victoza

You may be interested in these reviews

More reviews for: Lantus, Victoza

On eHealthMe, Lantus (insulin glargine recombinant) is often used to treat type 2 diabetes. Victoza (liraglutide) is often used to treat type 2 diabetes. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.